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EFFECTS OF A SHORT-TERM MINDFULNESS INTERVENTION ON 
DEPRESSION AND IMMUNE FUNCTION 
 
Pro-inflammatory cytokines have been implicated in the pathophysiology and 
maintenance of depression. This study investigated the effects of a short mindfulness 
intervention on pro-inflammatory correlates of depression (IL-6 and TNF-α) and self-
reported psychological health. Sixty-four college females were assigned to a four-week 
mindfulness training group or a contact-control group. Cytokines and psychological 
health were assessed at baseline, post-treatment, and 3-month follow-up (mindfulness 
group only). IL-6 and TNF-α significantly decreased from baseline to post-treatment in 
the mindfulness group only; these changes were sustained at 3-month follow-up. No 
between-group differences in psychological health emerged. Although reductions in pro-
inflammatory cytokines in the mindfulness condition were not attributable to 
psychological changes, they may serve to protect against the development of future 
depressive episodes. 
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Section One: Introduction 
Depression affects approximately 20.9 million US adults (9.5%) each year 
(NIMH, 2008).  Individuals with depression are impaired in many domains of functioning 
and are at higher risk for disease morbidity (Cuijpers & Smit, 2002; Rudisch & 
Nemeroff, 2003). Although depressive episodes can be effectively treated and may 
resolve without treatment, the high risk of relapse associated with unipolar major 
depression necessitates the identification of effective prevention and relapse-prevention 
strategies (Gotlib & Hammen, 2002). Adults who have experienced one major depressive 
episode have a 60% likelihood of recurrence, and this risk increases with each episode, 
such that those who have a history of three episodes have a 90% likelihood of 
experiencing a fourth (DSM-IV-TR, 2000).  
Associations between Depression and Innate Immunity 
 Nonspecific immune, behavioral, and physiological changes occur with the 
presence of infection or inflammation (Dantzer, 2001; 2006).  Such illness responses 
include fever, fatigue, difficulties with concentration, lack of interest in surroundings, 
reduced food intake, and behavioral disengagement (Dantzer, 2001; 2006; Kemeny, 
2006).  Collectively, these symptoms are referred to as “sickness behavior”.  Sickness 
behavior is considered a normal and adaptive response to acute immune threats (Dantzer 
2001; 2006; Dantzer et al., 2006).  It enhances survival by allowing the organism to 
conserve energy and disengage from situations or environments that are potentially 
harmful, thus promoting numerous healing and restorative processes (Kemeny, 2006).  
Although sickness behavior is regarded as an adaptive mechanism in particular contexts, 
it is also believed to contribute to the pathophysiology and maintenance of depression 
(Dantzer, 2001, 2006). 
 Sickness behavior is triggered by pro-inflammatory cytokines, including 
interleukins (e.g. IL-1, IL-6), interferons, and Tumor Necrosis Factor-alpha (TNF-α) 
(Dantzer, 2001, 2006; Dantzer et al., 2006).  Pro-inflammatory cytokines are often 
produced by innate immune cells (Dantzer, 2001; Dinan, 2008) and have been related to 
depression in the following ways: 1) Increased levels of circulating pro-inflammatory 
cytokines are observed in individuals with depressive symptomatology (Howren et al., 
2009; Zorrilla et al., 2001); 2) Individuals with an underlying inflammatory disease 
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experience symptoms of depression, likely due to disease-related release of pro-
inflammatory cytokines (Kemeney, 2006; Capuron et al., 2006); 3) Patients undergoing 
immunotherapy to treat cancer report psychological and behavioral changes consistent 
with depression upon short-term administration of a pro-inflammatory cytokine (Capuron 
et al., 2002) - especially individuals identified as “at-risk” (Capuron & Ravaud, 1999), 4) 
Animals injected with pro-inflammatory cytokines exhibit behavioral signs of sickness 
(Dantzer et al., 2006), and 5) Administration of anti-depressants to animals reduces levels 
of circulating pro-inflammatory cytokines and sickness behavior (Pollak & Yirmiya, 
2002).  Although this evidence is suggestive that pro-inflammatory cytokines cause 
depression, the directionality of this relationship is much more complex. The positive 
association between pro-inflammatory cytokines and depression is likely the result of a 
bidirectional process, in which immune products alter depressive symptoms, and vice 
versa (Howren et al., 2009).  Finally, and most pertinent to human research on 
depression, a recent meta-analysis shows that higher concentrations of IL-6 and TNF-α 
are more likely to be found in depressed participants than other pro-inflammatory 
markers (Dowlati et al., 2010). 
Effects of Mindfulness-Based Practices on Psychological States and Functioning 
 Mindfulness is a form of self-regulation of attention that originates from Eastern 
spiritual traditions and is conceptualized as nonjudgmentally bringing attention to internal 
and external events that arise within the present moment (Kabat-Zinn, 1994).  Sustained 
practice of mindfulness is thought to enhance positive personal qualities, such as 
awareness, insight, wisdom, and compassion, and to reduce suffering (Goldstein, 2002; 
Kabat-Zinn, 2003).  Although historically rooted in Buddhism, mindfulness has been 
adopted in secular form as an intervention for numerous psychological and physical 
ailments in Western settings (Baer, 2003).   
One of the most cited programs in mindfulness training is mindfulness-based 
stress reduction (MBSR), developed by Kabat-Zinn (1982, 1990).  MBSR is typically 
conducted in a group setting over the course of 8 weeks, with up to 30 members per 
group and weekly sessions lasting 2.0 - 2.5 hours. Versions with fewer and shorter 
sessions have been reported, with no loss of efficacy (Carmody & Baer, 2009).  In 
standard MBSR, patients are encouraged to practice mindfulness meditation exercises at 
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home for 45 minutes per day, six days a week during the intervention. Several studies 
have reported shorter practice times (20 minutes per day), again with no loss of efficacy 
(Carmody & Baer, 2009). Patients in MBSR are taught to observe their experiences, 
including uncomfortable or distressing thoughts and sensations, in a nonjudgmental, non-
avoidant fashion.  Practicing mindfulness is thought to increase patients' tolerance of 
unpleasant physical, cognitive, and emotional states through processes of repeated 
exposure or decentering (Baer, 2003; Keng, Smoski, & Robins, 2011).  Mindfulness 
practices taught in this program include hatha yoga, the body scan, sitting and walking 
meditations, and activities for cultivating mindfulness in daily life (Baer, 2006).   
Studies have shown mindfulness-based interventions to be efficacious for a 
variety of disorders including depression (Baer, 2003; Kabat-Zinn, 2003).  Self-reported 
benefits include reductions in mood disturbance, anxiety, difficulties with emotion 
regulation, and general psychological symptoms, and increases in psychological well-
being (see Keng et al., 2011 for a review).  Furthermore, mindfulness-based cognitive 
therapy (MBCT), a program closely based on MBSR that integrates mindfulness 
techniques with cognitive therapy, has demonstrated efficacy in the prevention of 
depression relapse for a period of one year following treatment, with individuals who 
have experienced three or more previous episodes (Teasdale et al., 2000; Segal, 2002; Ma 
& Teasdale, 2004).  Several studies have also shown that administering MBCT to acutely 
depressed participants yields clinically significant improvements (Eisendrath et al., 2008; 
Finucane & Mercer, 2006; Kenny & Williams, 2006; Kingston et al., 2007; Ree & 
Craigee, 2007). 
Effects of Mindfulness-Based Practices on Immunity 
Investigations examining the effects of mindfulness practice on immune and 
neuroendocrine function have yielded promising results.  Davidson et al. (2003) reported 
that participation in an 8-week MBSR program enhanced antibody titers to influenza 
vaccination in a sample of healthy but stressed adults.  Creswell et al. (2009) showed that 
patients diagnosed with HIV did not exhibit declines in CD4+ T lymphocytes upon 
completion of an 8-week MBSR intervention, whereas those in a control condition 
showed the expected declines.  Carlson et al. (2003) and Witek-Janusek et al. (2008) 
found significant reductions in pro-inflammatory cytokines among cancer patients 
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enrolled in an 8-week MBSR course, and these results were sustained at a one-year 
follow-up (Carlson et al., 2007).  Pace et al. (2009) and Tang et al. (2007) demonstrated 
that short-term meditation interventions were related to changes in immune and 
neuroendocrine functioning in healthy student samples following an experimental 
stressor.  Specifically, participants who received mindfulness training showed reductions 
in IL-6 (Pace et al., 2009) and cortisol (Tang et al., 2007), and increases in salivary IgA 
(Tang et al., 2007).  Short-term interventions consisted of two 50-minute sessions per 
week over the course of 6-weeks (Pace et al., 2009), and one 20-minute session for five 
consecutive days (Tang et al., 2007).  Lastly, some studies report that treatment 
adherence or home practice is positively associated with immune outcomes (Creswell et 
al., 2009; Pace et al., 2009), while others have not observed this effect (Carlson et al., 
2007). 
 Although results are encouraging, these investigations are not without 
methodological limitations.  Some studies have failed to include control conditions 
(Carlson et al., 2003; 2007), which significantly limits conclusions regarding the effects 
of MBSR on immunity.  Many studies have neglected to assess participants 
longitudinally (Davidson et al., 2003; Tang et al., 2007, Witek-Janusek et al., 2008, 
Creswell et al., 2009, Pace et al., 2009), making it difficult to evaluate if MBSR training 
has an enduring impact on immune processes. Pertinent to the current study, Pace et al. 
(2009) reported significantly reduced levels of IL-6 in participants in a short-term 
mindfulness intervention following an experimental stressor.  However, this effect was 
only seen in participants who reported high levels of meditation practice outside of 
sessions. Furthermore, although this group showed a significant change from pre-
treatment, no significant difference in level of IL-6 was observed between the meditation 
group and an attention-control group following treatment.  The lack of between-group 
effect may have been the result of using a non-psychologically vulnerable population or 
teaching a meditation practice not common to MBSR structure (i.e., compassion 
meditation).  Finally, while investigations examining the effects of mindfulness training 
on immunocompromised populations (e.g. HIV, cancer) are necessary and informative, 
they shed little light on the effects of mindfulness on immunity in otherwise healthy 
people with depression. Although diseases such as cancer share similarities with 
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depression, in that both conditions elevate circulating pro-inflammatory cytokines, it is 
difficult to interpret immunological findings from these populations.  That is, reductions 
in cytokines may be attributed to cancer recovery, reductions in depression, or both.  For 
this reason, it is necessary to investigate immunological changes following mindfulness 
training in a depressed but immunocompetent (or otherwise healthy) sample. 
Summary and Significance 
 Investigations examining the effects of mindfulness practice on previously and 
acutely depressed individuals show clinically significant improvements in functioning 
across a number of domains.  In addition, mindfulness practice appears to contribute to 
optimal immune functioning in both normal and clinical populations.  However, it 
remains unknown how mindfulness practice relates to immune changes in an 
immuncompetent depressed population.  There is also limited research on the long-term 
benefits participants receive following mindfulness-based interventions. 
 The current study investigated the effects of a short-term mindfulness intervention 
on psychological and immune functioning in a sample with moderate depressive 
symptoms.  This study assessed all participants from baseline to post-treatment.  
Participants in the mindfulness intervention were further evaluated at a 3-month follow-
up point to assess maintenance of treatment gains. Recent evidence (Tang et al., 2007; 
Pace et al. 2009) has demonstrated the potential benefits of short-term meditation practice 
on attention, emotion, and immunity, and showed that number of in-class hours is not 
strongly related to psychological outcomes in clinical and non-clinical samples (Carmody 
& Baer, 2009).  These findings suggest that short-term mindfulness interventions may 
provide benefits equivalent to those received in standard 8-week courses. 
 This study was designed to improve upon previous investigations of immune 
function and mindfulness training by: 1) monitoring an immune variable relevant to 
depressive symptoms, 2) longitudinally assessing immune and psychological outcomes, 
3) recruiting a psychologically vulnerable yet immunocompetent population, and 4) 
evaluating a mechanism of action responsible for reducing levels of pro-inflammatory 
immune correlates of depression. 
Study Aims and Hypotheses 
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 Aim 1.  To assess the longitudinal effects of a short-term mindfulness 
intervention on immunity and psychological health in a sample with moderate depressive 
symptoms. 
Hypothesis 1: Compared to a contact-control group, individuals participating in 
the mindfulness intervention will show reductions in two pro-inflammatory immune 
correlates of depression: interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), at 
immediate post-intervention assessment.  
Hypothesis 2: Compared to a contact-control group, individuals participating in 
the mindfulness intervention will experience reductions in self-reported depression, 
psychological and physical symptoms, and emotional dysregulation, and report 
improvements in psychological well-being and the tendency to be mindful in daily life at 
immediate post-intervention assessment.  
Hypothesis 3:  For participants in the mindfulness intervention, improvements in 
immunity and psychological health are expected to remain relatively stable at a 3-month 
follow-up assessment. 
 Aim 2.  To examine a possible mechanism of action responsible for reduction in 
pro-inflammatory immune correlates of depression. 
 Hypothesis 4:  At immediate post-intervention assessment, self-reported 
depression is expected to mediate the relation between treatment condition (mindfulness 
training vs. contact-control) and pro-inflammatory immune correlates of depression (IL-6 
and TNF-α).   
Although recent commentary (Howren et al., 2009) suggests that the association 
between depression and pro-inflammatory cytokines is likely the result of a bidirectional 
process, this study proposes that reductions in self-reported depression will lead to 
reductions in IL-6 and TNF-α.  Because mindfulness training targets disruptive cognitive 
and affective states through exercises emphasizing non-judgmental observation and 
acceptance, it seems reasonable to conclude that depressive symptoms will initially 
decrease, thereby diminishing potential mediators of pro-inflammatory immune 
activation (e.g., stress hormones). 
 
 
Copyright © Erin Celine Walsh, 2011 
 7 
Section Two: Method 
Overview of Study Design 
 This was a longitudinal intervention study of young women with moderate 
depressive symptoms.  Participants were assigned to either a mindfulness training or a 
contact-control condition.  Over the course of the investigation, participants completed 
three separate assessments: (a) before treatment initiation (baseline), (b) following 
treatment completion (6-week post-treatment assessment), and (c) 3-months after 
treatment completion (3-month follow-up; mindfulness training only).  At each time 
point, self-report data and salivary cytokines (IL-6, TNF-α) were assessed.  Data were 
collected between September 2010 and June 2011.  Complete information on participant 
flow is presented in the Results section (based on the consolidated standards of reporting 
trials [CONSORT] recommendations) and can be viewed in Figure 2.1.  
Participant Recruitment and Allocation 
 Initial Screening.  At the beginning of the Fall 2010 and Spring 2011 semesters, 
all students in introductory psychology at the University of Kentucky were offered the 
opportunity to participate in an in-class screening session for course credit.  During this 
session students filled out an approved screening questionnaire, the Center for 
Epidemiological Depression Scale (CES-D; Radloff, 1977), assessing their current level 
of depression.  Students who endorsed moderate symptoms of depression (scores ranging 
from 16-24) were contacted about their interest in participating in the current study and 
invited to complete a phone screening with the PI.   
Phone Screening. During the phone screening, potential participants were 
informed that the purpose of the study was to examine the effects of mindfulness 
meditation and yoga on health and well-being.  Potential participants were told that they 
would have to complete the phone screening to determine if they met eligibility criteria 
for the study. Eligibility criteria included: (a) endorsement of moderate depressive 
symptoms based upon self-report screening measure, (b) ages 18-25 years old, (c) female, 
(d) absence of suicidal ideation and suicide intent/plan, (d) absence of specific psychiatric 
disturbance (i.e., psychosis, bipolar disorder, PTSD), (e) absence of alcohol/drug 
dependence, (f) absence of immune disease or disorder (e.g., lupus, HIV), (g) absence of 
pregnancy, (h) not currently taking psychotropic agents (i.e., anti-depressants, 
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anxiolytics, anti-psychotics), statins, beta-blockers, anti-hypertensives, and nonsteroidal 
anti-inflammatory drugs, (i) willingness to be randomly assigned to the mindfulness or 
contact-control condition, and (j) ability to read, write and understand English. 
Group Assignment.  Students who met criteria for the study following the phone 
screening were assigned to a group.  Four groups were run each semester (Fall 2010, 
Spring 2011) to maximize the number of students who could be included in the study.  
Groups typically took place in the early mornings (i.e., 8am or 9am) to increase the 
likelihood that participants would adhere to study procedures on assessment days (see 
below for more detail).  Due to students’ schedule constraints, unrestricted randomization 
was not possible.  Therefore, group allocation procedures were as follows: a) If a student 
could participate in any of the available group times, she was randomized to a group; b) 
If a student could only participate in a restricted number of groups, she was randomized 
to a group that fit within her schedule; and c) If a student could only participate in one 
group due to schedule constraints, she was assigned to that particular group. The PI and 
students were blind to condition until all eligible participants were enrolled each 
semester.  Once study enrollment was complete, the PI randomized condition for each 
group (i.e., mindfulness training or contact-control) such that there were two mindfulness 
training and two contact-control groups offered each semester.  Participants learned of 
their condition status at the baseline assessment. All randomization procedures were 
completed with the assistance of an online random number generator (www.random.org). 
Study Procedures 
Baseline Assessment (Session 1).  At the agreed upon day and time, the PI met 
with each group, consisting of no more than 20 members each.  After completion of 
informed consent procedures, participants were asked to complete a packet of self-report 
measures assessing psychological and physical health status.  Additionally, participants 
were asked to provide a saliva sample for assessment of immune function.  Following 
collection of these measures, the PI provided participants with a brief overview of the 
study, including information on what they would be asked to do each week.  Contact-
control participants were informed that they could participate in a short-term mindfulness 
course the following semester, if interested.  Completion of the baseline assessment took 
50 minutes. 
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Mindfulness Training Sessions.  All mindfulness training sessions were 
completed in weeks 2-5 following baseline assessment.  Participants met in groups with 
the PI once per week to practice a specific mindfulness exercise.  Each session included 
35 minutes of mindfulness practice and 15 minutes of discussion (e.g., discussion of 
weekly experience, applicability of practice to daily life).  At the end of each session, 
participants were given a take-home CD of the mindfulness practice reviewed that week.  
Although it was optional, participants were encouraged to practice the mindfulness 
exercise while at home.  They were provided with daily tracking logs to record the 
number of minutes they attempted any formal meditation practice.  Only two participants 
attempted at-home practice over the course of the study.  Due to insufficient 
participation, this variable was not included in any final analyses. 
• Body Scan (Session 2):  The PI led participants through an exercise asking them to 
non-judgmentally observe sections of their body (e.g., toes, thighs, back, neck).  
Emphasis was placed on examining the sensations present in each location. Practice 
began and ended with attention to the breath, and is described in Segal et al. (2002). 
• Sitting Meditation (Sessions 3 & 5): The PI led participants through an exercise 
asking them to non-judgmentally observe: 1) the sensations of breathing, 2) the 
sensations present in the body, 3) the content of thoughts, 4) the presence of 
emotions, and 5) the sounds in the environment.  Practice began and ended with 
attention to the breath, and is described in Segal et al. (2002).  As sitting meditation 
receives considerable attention in mindfulness-based interventions, two sessions were 
devoted to this exercise.   
• Yoga (Session 4):  The PI led participants through light stretching exercises 
described in Kabat-Zinn (1990).  Participants were asked to focus nonjudgmentally 
on the particular sensations associated with bodily movement.  Modified poses were 
provided to participants who were unable to perform the full range of movement for a 
specific yoga pose.  Practice began and ended with focus on the breath.   
Contact-control Sessions.  Participants in the contact-control groups were asked 
to fill out questionnaires unrelated to the proposed study, in weeks 2-5, following 
baseline assessment.  Participants met in groups once per week, and each session lasted 
50 minutes. 
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Post-treatment Assessment.  During week 5, participants were reminded of the 
upcoming post-treatment assessment.  Participants were asked to return the following 
week at the agreed upon date, time, and location to complete assessment measures 
equivalent to those collected during the baseline session.  At this assessment, participants 
in the contact-control groups were invited to take part in a short-term mindfulness course 
the following semester.  Interested students were told to contact the PI if they wished to 
participate.  No contact-control participants opted to receive mindfulness training once 
the study was complete.  Completion of the post-treatment assessment session took 50 
minutes. 
3-month Follow-up Assessment (mindfulness training ONLY).  One month prior 
to the 3-month follow-up, the PI sent an email to mindfulness training participants 
reminding them of the final follow-up assessment. Participants met with the PI in small 
groups or individually to complete self-report and salivary assessment measures.  These 
sessions were held approximately three months following completion of the 6-week 
follow-up and lasted 40-50 minutes. A total of 21 participants attended this session and 
provided complete follow-up data. An additional three participants who were willing to 
complete the 3-month assessment yet could not attend due to being out of state were 
mailed a packet of self-report questionnaires but did not complete the salivary 
assessment.  These participants filled out and returned the packets within 2 weeks. 
Individuals in the contact-control group were not evaluated at the 3-month follow-
up. Based upon the University of Kentucky IRB requirements, participants in the contact-
control group were offered the described mindfulness intervention immediately following 
the 6-week post-treatment assessment. Because we could not predict whether participants 
would engage in the treatment at the start of the following semester, and thereby 
confound potential results, we chose not to assess them at this time point. 
Procedures for Enhancing Recruitment and Retention. To increase recruitment 
and retention, participants received course credit for the baseline assessment and each 
intervention session attended, and $20 was awarded to participants who attended all of 
these sessions.  In addition, $20 was offered for completion of the post-treatment and 3-
month follow-up sessions.  
Psychological Measures  
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Depressive Symptoms.  The Center for Epidemiologic Depression Scale (CES-D) 
is a 20-item inventory of depressive symptoms (Radloff, 1977).  The CES-D asks 
participants to rate their mood, thoughts, and behavior during the previous week on a 4-
point Likert scale.  CES-D items were scored such that higher total scores were indicative 
of greater depressive symptoms.  For the current study, scores ranging from 16-24 were 
used to screen for moderate symptoms of depression (Greden & Schwenk, 1997).  The 
CES-D was also administered at all study time points to monitor changes in depression 
severity.  For the present sample, internal consistencies were as follows: Baseline 
assessment (α = .80), post-treatment assessment (α = .79), 3-month follow-up (α = .65). 
Structured Clinical Interview for DSM-IV-TR Axis-I Disorders (SCID-I).  The 
SCID-I is a semi-structured interview used to diagnose the major Axis I DSM-IV-TR 
disorders (First et al., 1994). The SCID-I can be administered in full (i.e. all modules) or 
adapted to assess particular diagnostic classes of interest.  For the current study, the 
following modules were used during the phone screening to identify students who were 
ineligible due to the presence of particular disorders: Major Depressive Disorder (for 
severe symptom severity and suicidality), Substance Use Disorders (for alcohol/drug 
dependence), Bipolar I/II Disorder (for symptoms of severe depression or mania), and 
PTSD (for symptoms of severe anxiety and post-traumatic stress). Additionally, items 
measuring extreme psychotic symptoms were used to screen out participants with 
psychosis. 
Psychological Symptoms.  The Brief Symptom Inventory (BSI) is a 53-item self-
report instrument that assesses current psychopathology.  It contains nine symptom 
dimensions (Somatization, Obsessive-Compulsiveness, Interpersonal Sensitivity, 
Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation, and Psychoticism) 
and a Global Severity Index (GSI) that represents overall psychological distress.  Only 
the GSI was used in the present study. The BSI has demonstrated high internal 
consistency and significant associations with measures of similar constructs.  Participants 
completed the BSI at all three assessments.  Internal consistencies for GSI were as 
follows: Baseline assessment (α = .91), Post-treatment assessment (α = .89), 3-month 
follow-up (α = .91). 
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Emotion Regulation.  The Difficulties in Emotion Regulation Scale (DERS) is a 
36-item measure designed to assess deficits in emotion regulation (Gratz & Roemer, 
2004).  It includes six subscales: Lack of Acceptance of Emotional Responses, Lack of 
Emotional Awareness, Lack of Emotional Clarity, Limited Access to Effective Emotion 
Regulation Strategies, Lack of Impulse Control, and Difficulties Engaging in Goal-
Directed Behavior when experiencing distress.  Higher scores indicate greater emotion 
dysregulation.  In the development sample, the DERS demonstrated good test-retest 
reliability and significant associations with measures of similar constructs.  Participants 
completed the DERS at all three assessments. Internal consistencies for subscales were as 
follows: Baseline assessment (α ranging from .55-.88), Post-treatment assessment (α 
ranging from .74-.90), 3-month follow-up (α ranging from .79-.90). 
Physical symptoms. Self-perceived health was assessed with the Pennebaker 
Inventory of Limbic Languidness (PILL; Pennebaker, 1982). The PILL is a 54-item scale 
that measures the frequency of experiencing common physical symptoms and sensations 
(e.g., indigestion, headaches, nausea).  The PILL demonstrates high internal consistency 
and has been shown to correlate moderately with similar symptom scales (Pennebaker, 
1982).  For the present study, the PILL was completed at all three assessments and 
internal consistencies were as follows: Baseline assessment (α= .91), Post-treatment 
assessment (α= .92), 3-month follow-up (α= .96). 
 Mindfulness.  The Five Facet Mindfulness Questionnaire (FFMQ) is a 39-item 
self-report questionnaire designed to measure five facets of mindfulness: Observing, 
Describing, Acting With Awareness, Nonjudging of experience, and Nonreactivity to 
inner experience (Baer et al., 2006).  The FFMQ has shown good internal consistency for 
the five facets, and has demonstrated convergent and discriminant validity with several 
measures of related constructs.  Furthermore, all facets appear to be distinct from one 
another, exhibiting only moderate inter-correlations.  The FFMQ was completed at all 
three assessments and internal consistencies for subscales were as follows: Baseline 
assessment (α ranging from .81-.86), Post-treatment assessment (α ranging from .65-.91), 
3-month follow-up (α ranging from .74-.88). 
Well-being.  The Scales of Psychological of Well-Being (PWB) assess six 
subscales: Self-Acceptance, Environmental Mastery, Positive Relations with Others, 
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Personal Growth, Purpose in Life, and Autonomy (Ryff, 1989).  Higher scores reflect 
greater well-being.  Validity of the PWB scores is evidenced by significant positive 
correlations with measures of positive functioning (i.e. life satisfaction, self-esteem) and 
negative correlations with measures of negative functioning (i.e. depression) (Ryff, 
1989).  Participants completed the PWB at all three assessments.  Internal consistencies 
for subscales were as follows: Baseline assessment (α ranging from .64-.81), Post-
treatment assessment (α ranging from .73-.84), 3-month follow-up (α ranging from .72-
.86). 
Biological Measures 
Salivary cytokine samples. Although typically assessed in serum levels, studies 
show that IL-6 and TNF-α can be detected in whole unstimulated saliva (Sjogren et al., 
2006; Tishler et al., 1999; Pezelj-Ribaric et al., 2004), which is less invasive to collect 
than serum.  For the current study, the “passive drool” method was used to collect saliva 
samples. Twenty-four hours prior to each saliva sample collection, participants were 
asked to abstain from caffeine, tobacco, and alcohol products, illicit drugs, and exercise, 
until the assessment was complete (e.g., caffeine has immunosuppressive effects on pro-
inflammatory cytokines, see Horrigan et al., 2006).  To collect whole, unstimulated 
saliva, participants were asked to rinse their mouths with bottled water for 30 seconds 
and immediately dispose of the water into a paper cup, which was subsequently thrown 
away.  They were then instructed to wait 10 minutes before filling a small tube with 2-
5ml of their saliva (Sarstedt AG & CO).  Saliva was initially stored for 1-4 weeks ay -
25˚C before being transferred to -80˚C before assay. Immunoassays were performed at 
the Clinical Research Development and Operations Center (CR-DOC) at the University 
of Kentucky in Lexington, KY.   
Potential Covariates 
General health questionnaire.  Demographic information (age, race/ethnicity, 
marital status, current grade, religious affiliation), history of psychotherapy, and history 
of mindfulness practice were collected at baseline assessment.  At all assessment points, 
participants reported on health-related information, including: height and weight (to 
calculate BMI); history of health problems (e.g., allergies, cardiac illness, cancer, sleep 
disturbance); medications; illness (e.g., flu, cold); injury; vaccination status; 
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hospitalizations or surgeries; oral contraception use; menstrual cycle day/phase; oral 
health; caffeine, alcohol, and drug use; and amount of physical activity.  
The purpose of assessing this information was to control for potential variables 
that might affect levels of circulating pro-inflammatory cytokines.  Recent commentary 
(Segerstrom, 2009; O’Connor et al., 2009) recommends not controlling for variables 
unless there is a strong theoretical reason to do so.  Segerstrom (2009) argues that 
overfitting a model will have adverse effects on statistical power, results, and 
replicability.  Therefore, the only a priori variable that was entered as a covariate was oral 
contraception use.  For the remaining variables, correlations with IL-6 and TNF-α were 
computed. Only variables that were significantly correlated with salivary cytokines were 
included as covariates in subsequent analyses.  
Data Screening 
Several dependent variables did not meet the regression assumption of normality 
(i.e., the skewness for a given dependent variable was more than three times the standard 
error of its skewness).  In each such case, an attempt was made to achieve normality 
using nonlinear transformations (i.e., square root, log 10).  For the following variables, 
square root transformations were adequate for achieving normality: CES-D and Lack of 
Emotional Clarity (DERS).  For Lack of Impulse Control (DERS) and Lack of 
Acceptance of Emotional Responses (DERS), log 10 transformations were required to 
achieve normality. The following variables followed a poisson distribution and could not 
be transformed to normality using a nonlinear transformation: IL-6 and TNF-α.  The 
remaining outcome variables were normally distributed. Between-person covariates (e.g., 
BMI) were always grand-mean centered for use as predictors. 
Statistical Analyses 
Because some outcome data were missing at random, missing values were 
imputed using multiple random imputation in SAS PROC MI. To test the prediction that 
mindfulness training would be associated with lower levels of symptoms at post-
treatment assessment controlling for baseline levels, regression models were fit in SAS 
PROC REG with baseline levels of the relevant outcome measure in step 1, and condition 
(with mindfulness condition coded as 1, and contact-control condition coded as 0) in step 
2. For outcome variables that appeared to follow a poisson distribution and could not be 
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transformed to normality using a nonlinear transformation, similar regression models 
were fit in SAS PROC GENMOD specificying a poisson distribution for the dependent 
variable. Where significant effects of condition were not found, paired sample t-tests 
were also carried out to determine whether the outcome variable changed pre-post 
intervention in the whole sample, regardless of condition.  Analyses were carried out on 
each of 20 data sets, imputed using SAS PROC MI, and results were combined using 
SAS PROC MIANALYZE, which provides 95% confidence intervals for model 
estimates.  
To test the prediction that improvements in pro-inflammatory cytokine levels and 
psychological health would remain significant at the 3-month follow-up for those in the 
mindfulness intervention, two paired sample t-tests were carried out for each outcome 
that showed 1) significant changes from baseline to post-intervention in the full sample, 
or 2) a significant effect of the mindfulness condition on changes from baseline to post-
intervention.  The first paired sample t-test addressed whether the difference between 
baseline and post-intervention assessments was significant within the mindfulness 
condition, and the second addressed whether the difference between baseline and 3-
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Lost to follow-up at post-treatment (n=1) 
♦   Oversleeping 
 
 Lost to follow-up at 3-month assessment (n=7) 
♦   No contact/Unknown reason (n=6) 




Figure 2.1  
Flowchart for participant progress (based on the consolidated standards of reporting trials [CONSORT] recommendations) 
 
 Assessed for eligibility 
(n=79) 
Excluded  (n=15) 
♦   Not meeting inclusion criteria (n=13) 
• Psychotropic medication (n=6) 
• Immune disorder (n=4) 
• Age (n=2) 
• Psychiatric diagnoses (n=1) 
       
Analyzed  (n=30) 
♦   Excluded from analysis for cold/virus (n=1) 
Lost to follow-up at post-treatment (n=1) 
♦   No contact/Unknown reason   
 
 
Allocated to Mindfulness intervention (n=31) 
♦   Received allocated intervention (n=31) 
 
Allocated to Contact-control condition (n=33) 
♦   Received allocated intervention (n=33) 
 
Analyzed  (n=31) 





Group Assignment (n=64) 
Enrollment 
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Section Three: Results 
 Participant Flow 
Over the course of the study, 79 female students were assessed for study 
eligibility. Figure 2.1 provides information on accrual and retention of study participants 
(based on the consolidated standards of reporting trials [CONSORT] recommendations).  
Fifteen students from the initial pool of 79 were excluded for not meeting inclusion 
criteria (n=13) or were not interested in participating in the study once contacted (n=2). 
Sixty-four students met eligibility criteria and were assigned to either a mindfulness 
training group (n=31) or a contact-control group (n=33).  At the post-treatment 
assessment, 62 participants had completed the study (mindfulness training=30; contact-
control=32).  One participant dropped out for unknown reasons while the other missed 
the assessment due to oversleeping.  Twenty-four participants in the mindfulness group 
completed the 3-month follow-up assessment (retention=77%).  Out of the seven 
participants who withdrew from the study, six did not respond to the PI’s queries to 
return for the final follow-up session, and one reported she was not able to participate due 
to moving out-of-state.  Participants who completed the 3-month follow-up were similar 
to those who did not complete the 3-month follow-up with respect to age, race/ethnicity, 
current grade, marital status, and religious affiliation (all p’s > .10). 
Baseline Data  
Descriptive statistics for the sample by condition can be found in Table 3.1. There 
were no significant differences in age, race/ethnicity, current grade, or religious 
affiliation between the two conditions (age: t(62)  = -.18, p = .86; race: X2(2) = 2.19, p = 
.33, current grade: X2(2) = 1.44, p = .49, religious affiliation: X2(2) = 1.24, p = .74).  No 
significant correlations were found between these demographic variables and baseline 
levels of IL-6 or TNF-α.  Descriptives for outcome variables at baseline and post-
treatment for the full sample and within each condition can be found in Table 3.2. 
Aim 1: Treatment Effects 
Condition Effects on Salivary Cytokines 
Estimates and 95% confidence intervals for poisson regression models predicting 
the effect of condition on cytokine levels at post-treatment controlling for cytokine levels 
at baseline are presented in Table 3.3.  As noted earlier, oral contraceptive use was 
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controlled for a priori.  Upon inspection of correlations between levels of IL-6, TNF-α, 
and variables measured in the general health questionnaire, only one significant 
correlation emerged: TNF-α and BMI were positively correlated.  Therefore, oral 
contraceptive use was controlled for in the model predicting IL-6, and both oral 
contraceptive use and BMI (standardized) were controlled for in the model predicting 
TNF-α. Results indicated that, controlling for baseline levels of IL-6, participation in 
mindfulness training predicted lower IL-6 at the post-treatment assessment (BCONDITION= -
.61, SE = .17, 95% CI: -.95 to -.26, p = .0006).  See Figure 3.1 for a graph of condition 
effects on IL-6 from baseline to post-treatment. Likewise, controlling for baseline levels 
of TNF-α, participation in mindfulness training was associated with lower levels of TNF-
α at post-treatment (BCONDITION = -.37, SE = .23, 95% CI: -.86 to -.12, p = .04).  See 
Figure 3.2 for a graph of condition effects on TNF-α from baseline to post-treatment.  
Condition Effects on Self-Report Outcomes 
Estimates and 95% CIs for regression models predicting post-treatment 
depression scores indicated that change in depression was not significantly associated 
with condition (CES-D: BCONDITION = 1.06, SE = 1.22, 95% CI: .67 to 1.56, p = .39). 
However, depression decreased from baseline to post-treatment regardless of condition 
(CES-D: Mean Difference: -3.10, 95% CI = -4.59 to -1.61, t = -4.08, p < .0001).  Results 
of regression estimates predicting psychological symptoms as measured by the GSI 
(BSI), Deficits in Emotion Regulation as measured by the DERS, and Physical 
Symptoms as measured by the PILL also indicated that change in these measures was not 
significantly associated with condition.  However, general psychological symptoms 
decreased from baseline to post-treatment regardless of condition (Global Severity Index, 
GSI, Mean Difference = -.13, 95% CI = -.053 to -.20, t = 2.45, p = .02).   
With regard to mindfulness facets, those in the mindfulness condition had higher 
levels of Observe at post-treatment than those in the contact-control condition controlling 
for baseline levels (BCONDITION = .34, SE = .18, 95% CI: .0079 to .69, p = .05), and those 
in the contact-control condition had higher levels of Nonjudging at post-treatment than 
those in the mindfulness condition controlling for baseline levels (BCONDITION = -.35, SE = 
.11, 95% CI: -.57 to -.12, p = .0025). See Figures 3.3 and 3.4 for graphs of respective 
results. Levels of other facets of mindfulness at post-treatment were not significantly 
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associated with condition when controlling for baseline levels.  With regard to 
psychological well-being, condition was not significantly associated with levels of 
psychological well-being at post-treatment controlling for baseline levels.  However, 
levels of Personal Growth increased from baseline to post-treatment regardless of 
condition (Mean Difference = .11, 95% CI = .0021 to .21, t = 2.00, p = .045).  
Longitudinal Outcomes within the Mindfulness Training Condition 
Additional within-group analyses were conducted within the mindfulness 
condition to investigate 1) the significance of within-condition effects of time at post-
treatment, and 2) whether significant changes within the mindfulness condition at post-
treatment were maintained at 3-month follow-up (i.e., whether the difference between 
baseline and 3-month measures were also significant in expected directions).  Results 
indicate that, within the mindfulness condition, IL-6 decreased significantly from 
baseline at both post-treatment and 3-month follow-up assessments (Mean Difference 
from baseline to post-treatment = -.58, 95% CI = -.27 to -.98, t = -2.38, p = .019; Mean 
Difference from baseline to 3-month follow-up = -.75, 95% CI = -.45 to -1.87, t = -1.98, 
p = .054).  Identical analyses carried out for TNF-α suggested that, although TNF-α 
decreased significantly from baseline to post-treatment, the decrease from baseline to the 
3-month follow-up assessment was only marginally significant, suggesting that changes 
in TNF-α may have been less robust (Mean Difference from baseline to post-treatment = 
-.53, 95% CI = -1.05 to -.41, t = -2.38, p = .008; Mean Difference from baseline to 3-
month follow-up = -.45, 95% CI = -1.48 to .72, t = -1.21, p = .11).  Results for depression 
scores indicated that the CES-D decreased significantly from baseline to post-treatment 
(Mean Difference from baseline to post-treatment = -2.71, 95% CI = -3.46 to -1.83, t = -
2.35, p = .018) and from baseline to the 3-month follow-up (Mean Difference from 
baseline to 3-month follow-up = -2.76, 95% CI = -5.19 to -.32, t = -2.25, p = .026).  
Additionally, decreases in GSI, though only marginally significant at post-treatment, 
were statistically significant at the 3-month follow-up (Mean Difference from baseline to 
post-treatment = -.10, 95% CI = -.22 to .04, t = -1.53, p = .13; Mean Difference from 
baseline to 3-month follow-up = -.25, 95% CI = -.38 to -.13, t = -2.51, p = .0075).  With 
regard to the Observe facet of the FFMQ, increases were significant at post-treatment 
(Mean Difference from baseline to post-treatment = .29, 95% CI = .14 to .58, t = 2.01, p 
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= .044) but not at 3-month follow-up (Mean Difference from baseline to 3-month follow-
up = .31, 95% CI = -.35 to .98, t = .94, p = .35).  Finally, results indicate that changes in 
Personal Growth were not significant at either from baseline to post-treatment or from 
baseline to the 3-month follow-up (Mean Difference from baseline to post-treatment = 
.13, 95% CI = -.08 to .35, t = 1.22, p = .22; Mean Difference from baseline to 3-month 
follow-up = .11, 95% CI = -.25 to .48, t = .63, p = .53). 
Aim 2: Potential Mediators of Cytokine Outcomes 
Because there were no effects of mindfulness training on depression, 
hypothesized meditational models were not considered. However, several post-hoc 
regression models were fit and combined using PROC MIANALYZE to explore other 
potential mediators of the effects on salivary cytokines.  First, because there were 
condition effects on changes in the Observe subscale of the FFMQ, this scale was 
examined as a potential mediator.  However, changes in the Observe subscale were not 
significantly related to cytokines at time 2 controlling for cytokines at time 1 (IL-6: 
BOBSERVECHANGE = -.049, SE = .16, 95% CI: -.28 to .17, p = .76; TNF-α: BOBSERVECHANGE 
= -.074, SE = .15, 95% CI: -.12 to .20, p = .62).  Next, we explored condition effects on 
changes in several health behaviors, including physical activity, caffeine and alcohol 
consumption.  Results indicated that condition was not associated with health behaviors 
at time 2 controlling for the relevant health behaviors at time 1 (Minutes of Physical 
Activity per Week: BCONDITION = 7.03, SE = 3.75, 95% CI: -1.59 to 1.12, p = .85; Units of 
Caffeine per Day: BCONDITION = -2.09, SE = 2.30, 95% CI: -5.91 to 1.73, p = .93; Units of 
Alcohol per Week: BCONDITION = 2.48, SE = 4.16, 95% CI: -6.08 to 1.10, p = .95).  
Therefore, condition effects on health behaviors do not appear to be responsible for 
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Table 3.1 
Descriptives by Sample 
 
Variable 










Age: M (SD) 19.15 (.17) 19.11 (.16) 
Grade Level: N (%)    
     Freshman 22 (70%) 27 (82%) 
     Sophomore 6 (20%) 3 (9%) 
     Junior 3 (10%) 3 (9%) 
Race: N (%)   
     Caucasian 25 (81%) 30 (91%) 
     African-American 4 (13%) 1 (3%) 
     Asian 2 (6%) 2 (6% 
Religious Affiliation: N (%)   
     Christian 26 (84%) 25 (76%) 
     Hindu 1 (4%) 1(3%) 
     No Religious Affiliation 2 (6%) 5 (15%) 
     No Answer 2 (6%) 2 (6%) 
Note. Standard Deviations and Within-group Percentages in Parentheses 
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Table 3.2 
Means and Standard Deviations for Outcome Variables at Baseline and Post-treatment by Condition 















3.58 (4.55) 3.14 (5.36)  3.50 (5.14) 2.20 (2.24)  3.66 (4.01) 4.04 (7.14) 
TNF-α 
 
2.21 (2.95) 1.64 (1.68)  2.13 (3.76) 1.33 (1.42)  2.29 (1.93) 1.94 (1.87) 
CES-D total 
 
12.53a (6.25) 9.44b (5.64)  13.26a (5.67) 10.30b (5.89)  11.85a (6.76) 8.63b (5.36) 
GSI (BSI) 
 
.51a (.30) .40b (.25)  .53 (.31) .43 (.24)  .48a (.30) .37b (.26) 
PILL total 
 
1.81 (.36) 1.75 (.39)  1.78 (.33) 1.73 (.34)  1.84 (.38) 1.77 (.43) 
Lack of Emotional 
Awareness (DERS) 
 
2.58 (.72) 2.47 (.70)  2.56 (.82) 2.44 (.71)  2.60 (.64) 2.50 (.71) 
Lack of Emotional Clarity 
(DERS) 
 
2.14 (.63) 2.20 (.60)  2.26 (.76) 2.27 (.64)  2.02 (.45) 2.12 (.55) 




1.90 (.70) 1.94 (.80)  1.84 (.58) 2.00 (.86)  1.95 (.80) 1.88 (.74) 
Limited Access to 
Strategies (DERS) 
 
1.73 (.47) 1.71 (.53)  1.77 (.45) 1.68 (.48)  1.68 (.50) 1.75 (.58) 
         
     
23 
Table 3.2 (Continued) 
Lack of Impulse Control 
(DERS) 
 
1.57 (.38) 1.53 (.45)  1.54 (.37) 1.45 (.41)  1.59 (.39) 1.60 (.48) 
Difficulties with Goal-Directed 
Behavior (DERS) 
 
2.87 (.77) 2.81 (.83)  2.91 (.86) 2.90 (.84)  2.82 (.70) 2.73 (.82) 
Observe (FFMQ) 
 
3.44 (.83) 3.49 (.82)  3.32a (.83) 3.57b (.75)  3.54 (.82) 3.41 (.89) 
Describe (FFMQ) 
 
3.40 (.67) 3.39 (.78)  3.29 (.80) 3.35 (.83)  3.46 (.53) 3.43 (.75) 
Nonjudging (FFMQ) 
 
3.81 (.68) 3.88 (.64)  3.80 (.69) 3.70 (.65)  3.81a (.67) 4.04b (.60) 
Nonreactivity (FFMQ) 
 
2.88 (.60) 2.89 (.50)  2.86 (.67) 2.90 (.48)  2.89 (.53) 2.88 (.52) 
Acting with Awareness 
(FFMQ) 
 
3.58 (.65) 3.47 (.69)  3.50 (.66) 3.38 (.74)  3.66 (.64) 3.55 (.63) 
Autonomy (PWB) 
 
4.18 (.72) 4.16 (.73)  4.17 (.74) 4.18 (.78)  4.20 (.72) 4.14 (.69) 
Environmental Mastery (PWB) 
 
4.27 (.69) 4.40 (.61)  4.21 (.73) 4.40 (.57)  4.33 (.67) 4.39 (.66) 
Self-Acceptance (PWB) 
 
4.71 (.66) 4.72 (.68)  4.79 (.64) 4.90 (.57)  4.64 (.68) 4.55 (.75) 
Positive Relations (PWB) 
 
4.67 (.79) 4.75 (.78)  4.56 (.82) 4.64 (.80)  4.78 (.76) 4.85 (.77) 
Purpose in Life (PWB) 
 
4.70 (.55) 4.69 (.60)  4.75 (.58) 4.76 (.65)  4.66 (.52) 4.63 (.56) 
Personal Growth (PWB) 4.91a (.59) 5.02b (.67)  5.01 (.62) 5.04 (.68)  4.81a (.56) 5.00b (.67) 
Note: Differing superscripts indicate significant differences between baseline and post-treatment values (p<.05).
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Table 3.3 
Estimates for Poisson Regression Models Predicting IL-6 and TNF-α Using PROC 
MIAnalyze  
 
Variable Estimate 95% CI for Estimate 
Interleukin-6   
Oral Contraceptive Use -.70* -1.06 to -.34 
Time 1 IL-6 .30* .18 to .41 
MBSR Condition -.60* -.95 to -.26 
Tumor Necrosis Factor-α   
Oral Contraceptive Use -.66* -1.14 to -.17 
Body Mass Index .12 -.10 to .35 
Time 1 TNF-α .30* .15 to .44 
MBSR Condition -.37* -.86 to -.12 
Note: *p < .01
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Figure 3.1  
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Figure 3.2  
Effect of Condition on Change in TNF-α Pre-to-Post-Treatment 
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Figure 3.3 
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Figure 3.4 





Section Four: Discussion 
 The present study investigated whether a short-term mindfulness-based 
intervention could reduce both immunological and psychological features of depression 
in a sample of moderately depressed college women.  The first hypothesis was that 
participation in the mindfulness group would be associated with post-treatment 
reductions in pro-inflammatory immune correlates of depression: IL-6 and TNF-α. This 
hypothesis was supported. Compared to a contact-control group, participants in the 
mindfulness intervention showed significant reductions in these two immune variables. 
The second hypothesis was that participation in the mindfulness group also would be 
associated with changes in several self-reported psychological variables, including 
depression, general distress, well-being, emotion regulation, and mindfulness. This 
hypothesis was not supported.  Although improvements in several psychological 
variables were observed, very few between-group differences emerged.  The Observe 
facet of the FFMQ was shown to significantly increase in the mindfulness group only, 
while the Nonjudging facet increased only in the contact-control group.  The third 
hypothesis was that, for participants in the mindfulness intervention, improvements in 
immune and psychological health variables would remain stable over the 3-month 
follow-up period. This hypothesis was partially supported. Within the mindfulness group, 
reductions in both pro-inflammatory cytokines were sustained at a 3-month follow-up 
assessment. However, because minimal differences in self-reported psychological 
variables emerged pre-post-treatment, there were very few treatment effects in this 
domain to monitor at the 3-month follow-up. While increases in the Observe facet were 
significant from baseline to post-treatment in the mindfulness condition, these changes 
were not maintained; however, reductions in psychological distress as measured by the 
Global Severity Index (GSI) were significant from baseline to post-treatment and 
maintained at 3-month follow-up in the mindfulness condition. The fourth hypothesis was 
that self-reported depression at post-treatment would mediate the relationship between 
participation in mindfulness training and changes in IL-6 and TNF-α. This hypothesis 
was not tested because, contrary to expectations, the relation between participation in 
mindfulness training and change in depression was not significant.  
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 Results for IL-6 and TNF-α are consistent with other investigations examining the 
effects of short-term (e.g., Tang et al., 2007) or full-length (e.g., Carlson et al., 2007) 
mindfulness-based interventions on immunity. For example, significant reductions in pro-
inflammatory cytokines have been observed in cancer patients enrolled in 8-week 
mindfulness courses (Carlson et al. 2003; Witek-Janusek et al., 2008) and these results 
were sustained at a one-year follow-up (Carlson et al., 2007).  Similar to these findings, 
we observed significant reductions in cytokines pre-post treatment for the mindfulness 
training group only and found that these improvements were maintained at 3-months 
following treatment completion.  However, this investigation is the first to demonstrate 
such effects in a dysphoric yet immunocompetent sample and the first to include both a 
control group and a post-treatment follow-up assessment.  Furthermore, we provide 
evidence that such reductions can occur with relatively brief training in mindfulness 
practices.  The current findings support the notion that mindfulness training may promote 
immune responses that contribute to physical health (e.g., less inflammation).  It 
underscores the importance of examining such processes in future samples with 
depressive disorders because doing so may illuminate the mechanisms by which 
mindfulness contributes to improvements in psychological health. 
The failure of the current study to find changes related to mindfulness training in 
self-reported psychological variables is inconsistent with overwhelming evidence 
suggesting that mindfulness training has direct benefits on many of the constructs 
measured in this study (see Keng et al., 2011 for a review). Several factors may account 
for these findings. One possibility is the low level of psychological distress in the sample. 
Participants were recruited if they reported moderate levels of depressive symptoms 
(scores of 16-24 on the CES-D) at the initial screening; however, mean levels of 
depression had fallen to 12.53 (indicating minimal to mild symptoms) by the first session, 
suggesting that the initial screening scores may have been temporary elevations related to 
situational stress, rather than indicators of sustained depressive symptoms. As evidence 
for this point, participants showed further decreases in depressive symptoms from pre- to 
post-treatment. These changes are likely attributable to further regression to the mean as 
the semester progressed. A second possibility is that the “dose” of mindfulness training in 
the current study was not strong enough to effect changes in self-report measures that go 
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beyond regression to the mean.  Perhaps if participants had been provided with additional 
training sessions (i.e., more than 4) or longer training sessions (i.e., more than 50 
minutes), robust between-group differences in psychological variables may have 
emerged. Several previous studies with comparable training lengths have reported 
reductions in psychological symptoms or improvements in well-being in student samples 
(Tang et al., 2007; Sauer et al., under review), while others have not (Pace et al., 2009). 
Thus, this is an important area for further inquiry. A third potential factor is the non-
treatment seeking status of the sample. Although they had reported moderate levels of 
depression at the initial screening, they were not recruited from a help-seeking 
population, but instead completed the study to meet a research participation requirement. 
They engaged in very little home practice and may have had low levels of motivation to 
learn mindfulness skills. Although a recent review (Carmody & Baer, 2009) found no 
significant relationship between treatment duration and psychological symptom 
reduction, suggesting that short treatment formats may be as effective as longer ones, 
most of the reviewed studies used clinical populations or nonclinical samples seeking 
help for stress reduction.  
Despite its nonsignificant relationships with changes in self-reported 
psychological functioning, the short-term mindfulness training provided in this study was 
sufficient to lead to significant reductions in the two immune variables studied. It is 
therefore important to consider how these immune changes occurred. It appears that they 
are not accounted for by the self-report variables measured here.  However, it is entirely 
possible that we did not assess variables that could directly account for the significant 
reductions in salivary cytokines.  One particularly likely candidate is rumination.  
Rumination is a transdiagnostic process, meaning that it is present in a multitude of 
psychological disorders.  Although definitions vary, it can be thought of as repetitively 
focusing on one’s emotional experience, as well as the causes, consequences, and 
implications of it (Aldao, Nolen-Hoeksema, & Schweizer, 2010).  Individuals who 
ruminate believe that it will help them solve problems or improve mood, however, 
investigations show that rumination interferes with adaptive problem-solving (Aldao, 
Nolen-Hoeksema, & Schweizer, 2010) and perpetuates negative mood (Thomsen, 
Mehlsen, Christensen, & Zachariae, 2003).  Mindfulness is thought to reduce rumination 
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by teaching participants to defuse or decenter from thoughts via nonreactive observation 
or to focus on other present-moment stimuli, such as the breath or bodily sensations 
(Baer, 2007; Uebelacker et al., 2010).  Investigations have shown that mindfulness 
training is efficacious in reducing rumination in samples experiencing depressive or 
general psychological symptoms (Kingston et al., 2007; Heeren & Philippot, 2011).  
Additionally, Sauer, Walsh, Lykins and Eisenlohr-Moul (under review) showed that even 
short-term, 3-session training in separate mindfulness practices led to significant 
reductions in rumination.  In fact, rumination was the only symptom that all mindfulness 
practices significantly and robustly reduced.  In regard to physiological correlates, there 
is prospective evidence suggesting that rumination is associated with self-reported 
somatic complaints (e.g., Thomsen et al., 2004a).  Rumination is also linked to increases 
in morning levels of cortisol (Schlotz et al., 2004), elevated leukocytes (Thomsen et al., 
2004b), and reductions in T-lymphocytes (Denson et al., 2010). These findings suggest 
that rumination may have negative effects on one’s physical health.  Because mindfulness 
training is associated with reductions in ruminative tendencies, it is entirely plausible that 
such changes may have mediated effects on cytokine levels in the present study.  
 Limitations 
 The present study has several limitations worth noting.  First, as mentioned 
earlier, participants with moderate depressive symptoms were recruited with a widely 
used screening measure, the Center for Epidemiological Studies Depression Scale (CES-
D; Radloff, 1977). Although scores within the “moderate” depression range (i.e., 16-24) 
are thought to indicate concern for depressive disorders, the presence of specific 
depressive disorders was not thoroughly assessed, and many individuals’ scores had 
decreased from the initial screening session to the baseline assessment.  Although a 
structured interview was used during the phone screening, we did not require that 
participants meet criteria for major depressive episodes or dysthymia to be admitted into 
the study. The structured interview was only utilized to rule out individuals who reported 
the presence of certain diagnoses (e.g., PTSD) or psychological features (e.g., 
suicidality). Future investigations examining the effects of mindfulness training on 
depression would benefit from using structured clinical interviews, such as the SCID-I, to 
recruit participants meeting criteria for DSM-IV depressive disorders.  If using a short 
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screening measure of depression, the Beck Depression Inventory (BDI) may be preferred 
to the CES-D because it has been shown to have fewer false positives in regard to 
adolescent or young adult samples (Roberts et al., 1991).  If the CES-D is utilized, 
researchers should consider using higher cut scores when selecting for depressed young 
adults (Lawrence et al., 2006). 
 Second, the current study did not document longitudinal changes in the contact-
control group due to a requirement by the IRB that mindfulness training should be 
offered to control participants the semester following the 6-week post-treatment 
assessment (all declined). Future studies should assess both intervention and control 
groups at all three time points.  This will allow researchers to more thoroughly assess 
whether maintained effects are the result of treatment or time. 
 Finally, the current study did not offer a full-length, empirically supported 
mindfulness training program, such MBSR or MBCT, to participants with depressive 
symptoms.  These programs, which typically include 8 weekly 2-hour sessions, have 
been shown to have significant therapeutic effects on symptoms and well-being (e.g., 
Keng et al., 2011) and to reduce the risk of depressive relapse (e.g., Piet & Hougaard).  It 
is quite possible that additional sessions or treatment components not offered in the 
current study may be necessary for cultivating meaningful increases in mindfulness and 
emotion regulation and for increasing awareness of emotional and cognitive processes so 
that participants can accurately reflect and report on changes that occur over the course of 
treatment. 
 Finally, although the present study included a longer follow-up than is typical for 
this literature, an even longer follow-up would have been useful for examining whether 
the change in immune variables seen at post-treatment and 3-month follow-up was 
associated with protection against future episodes of depressive symptoms.  
Conclusion 
 Despite the lack of condition effects on changes in numerous psychological 
variables, the current study showed that only mindfulness training led to improvements in 
immune functioning.  Specifically, levels of salivary pro-inflammatory cytokines were 
reduced at post-treatment in the mindfulness condition, and these effects were maintained 
at a 3-month follow-up assessment.  This is noteworthy because it demonstrates that even 
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short-term training in mindfulness could have important implications for physical and 
psychological health.  There is some evidence to suggest that higher baseline levels of 
pro-inflammatory cytokines in healthy individuals are risk factors for the development of 
disorders such as depression (Wichers et al., 2006).  Although the directionality of the 
inflammation-depression relation is complex (Howren et al., 2009), it could be that 
reductions in pro-inflammatory cytokines of the kind seen in the mindfulness condition 
























Copyright © Erin Celine Walsh, 2011
  35  
References 
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental 
disorders, (4th ed., text revision). Washington, DC: American Psychiatric 
Association. 
Aldao, A., Nolen-Hoeksema, S.N., & Schweizer, S. (2010). Emotion-regulation strategies 
across psychopathology: A meta-analytic review. Clinical Psychology Review, 30, 
217-237. 
Baer, R.  (2003).  Mindfulness training as a clinical intervention: a conceptual and 
empirical review.  Clinical Psychology: Science and Practice, 10(2), 125-143. 
Baer, R. (Ed.). (2006). Mindfulness-based treatment approaches: Clinician's guide to 
evidence base and applications.  Burlington, MA: Elsevier Inc. 
Baer, R. A., Smith, G. T., Hopkins, J., Krietemeyer, J., & Toney, L.  (2006). Using self-
report assessment methods to explore facets of mindfulness.  Assessment, 13(1), 
27-45. 
Baer, R.A. (2007). Mindfulness, assessment, and transdiagnostic processes. 
Psychological Inquiry, 18(4), 238-241. 
Baron, R. M., & Kenny, D. A. (1986). The moderator-mediator variable distinction in 
social psychological research: Conceptual, strategic, and statistical considerations. 
Journal of Personality and Social Psychology, 51, 1173-1182. 
Capuron, L. and Ravaud, A. (1999). Prediction of the depressive effects of interferon-α 
therapy by the patient’s initial affective state. New England Journal of Medicine, 
340, 1370. 
Capuron, L., Gumnick, J.F., Musselman, D.L, Lawson, D.H., Reemsnyder, A., Nemeroff, 
C.B., and Miller, A.H. (2002). Neurobehavioral effects of interferon-α in cancer 
patients: Phenomenology and paroxetine responsiveness of symptom dimensions.  
Neuropsychopharmacology, 26(5), 643-652. 
Capuron, L., Miller, A., and Irwin, M.R. (2006). Psychoneuroimmunology of depressive 
disorder: Mechanisms and clinical implications. In R. Ader (Ed.), 
Psychoneuroimmunology (pp. 509-530), New York: Academic Press. 
Carlson, L.E., Speca, M., Faris, P., and Patel, K.D. (2007). One year pre-post intervention 
follow-up of psychological, immune, endocrine and blood pressure outcomes of 
  36  
mindfulness-based stress reduction (MBSR) in breast and prostate cancer 
outpatients.  Brain, Behavior, and Immunity, 21, 1038-1049. 
Carlson, L.E., Speca, M., Patel, K.D., and Goodey, E. (2003). Mindfulness-based stress 
reduction in relation quality of life, mood, symptoms of stress, and immune 
parameters in breast and prostate cancer outpatients.  Psychosomatic Medicine, 
65, 571-581. 
Carmody, J. & Baer, R.A. (2009). How long does a mindfulness-based stress reduction 
program need to be? A review of class contact hours and effect sizes for 
psychological distress. Journal of Clinical Psychology, 65(6), 627-638. 
Creswell, J.D., Myers, H.F., Cole, S.W., and Irwin, M.R. (2009). Mindfulness meditation 
training effects on CD4+ T lymphocytes in HIV-1 infected adults: A small 
randomized controlled trial. Brain, Behavior, and Immunity, 23, 184-188. 
Creswell, J.D., Way, B.M., Eisenberger, N.I., & Lieberman, M.D. (2007). Neural 
correlates of dispositional mindfulness during affect labeling. Psychosomatic 
Medicine, 69, 560-565. 
Cuijpers, P. and Smit, F. (2002). Excess mortality in depression: A meta-analysis of 
community studies. Journal of Affective Disorders, 72, 227-236. 
Dantzer, R. (2001). Cyokine-induced sickness behavior: Where do we stand?  Brain, 
Behavior, and Immunity, 15, 17-24.  
Dantzer, R. (2006). Cyokine, sickness behavior, and depression. Neurologic Clinics, 24, 
441-460. 
Dantzer, R., Bluthe, R.M., Castanon, N., Kelley, K.W., Konsman, J.P., Laye, S., Lestage, 
J., and Parnet, P. (2006). Cytokines, sickness behavior, and depression. In R. Ader 
(Ed.), Psychoneuroimmunology (pp. 281-318), New York: Academic Press. 
Davidson, R.J., Kabat-Zinn, J., Schumacher, J., Rosenkranz, M., Muller, D., Santorelli, 
S.F., Urbanowski, F., Harrington, A., Bonus, K., & Sheridan, J.F. (2003). 
Alterations in brain and immune function produced by mindfulness meditation. 
Psychosomatic Medicine, 65, 564-570. 
Denson, T.F., Spanovic, M.S., & Miller, N. (2009). Cognitive appraisals and emotions 
predict cortisol and immune responses: A meta-analysis of acute laboratory social 
stressors and emotion inductions. Psychological Bulletin, 135(6), 823-853. 
  37  
Dinan, T.G. (2008). Inflammatory markers in depression. Current Opinion in Psychiatry, 
22, 32-36. 
Eisendrath, S. J., Delucchi, K., Bitner, R., Fenimore, P., Smit, M., & McLane, M. (2008). 
Mindfulness-based cognitive therapy for treatment-resistant depression: A pilot 
study. Psychotherapy and Psychosomatics, 77, 319-320. 
Finucane, A. & Mercer, S. W. (2006). An exploratory mixed methods study of the 
acceptability and effectiveness of mindfulness-based cognitive therapy for 
patients with active depression and anxiety in primary care. BMC Psychiatry, 6: 
14. 
First, M.B., Spitzer, R.L., Gibbon, M., and Williams, J.B.W.  (1994). Structured clinical 
interview for axis 1 DSM-IV disorders. New York: Biometric Research 
Department, New York State Psychiatric Institute. 
Goldstein, J. (2002). One Dharma: The emerging Western Buddhism. San Francisco: 
Harper Collins. 
Gotlib, I. & Hammen, C. (2002). Introduction. In I. Gotlib and C. Hammen (Eds.), 
Handbook of depression (pp. 1-20). New York: Guilford Press. 
Gratz, K. L, & Roemer, L. (2004). Multidimensional assessment of emotion regulation 
and dysregulation: Development, factor structure, and initial validation of the 
Difficulties in Emotion Regulation Scale. Journal of Psychopathology and 
Behavioral Assessment, 26, 41-54. 
Greden, J.F. & Schwenk, T.L. (1997). Major mood disorders. In: D.J. Knesper, M.B. 
Riba, and T.L. Schwenk (Eds.). Primary Care Psychiatry. Philadelphia, PA: W.B. 
Saunders Co. 
Heeren, A. & Philippot, P. (2011). Changes in ruminative thinking mediate the clinical 
benefits of mindfulness: Preliminary findings. Mindfulness, 2, 8-13. 
Hölzel, B.K., Ott, U., Gard, T., Hempel, H., Weygandt, M., Morgen, K., and Vaitl, D. 
(2008). Investigation of mindfulness meditation practitioners with voxel-based 
morphometry. Social Cognitive and Affective Neuroscience, 3(1), 55-61. 
Horrigan, L.A., Kelly, J.P., & Connor, J.P. (2006). Immunomodulatory effects of 
caffeine: Friend or foe? Pharmacology and Therapeutics, 111(3), 877-892. 
  38  
Howren, M.B., Lamkin, D.M., and Suls, J. (2009). Associations of depression with c-
reactive protein, IL-1, and IL-6: A meta-analysis. Psychosomatic Medicine, 71, 
171-186. 
Kabat-Zinn, J.  (1982).  An outpatient program in behavioral medicine for chronic pain 
patients based on the practice of mindfulness meditation: Theoretical 
considerations and preliminary results.  General Hospital Psychiatry, 4, 33-47. 
Kabat-Zinn, J.  (1990).  Full catastrophe living: Using the wisdom of your body and mind 
to face stress, pain, and illness.  New York: Delacorte. 
Kabat-Zinn, J.  (1994).  Wherever you go, there you are: Mindfulness meditation in 
everyday life.  New York: Hyperion. 
Kabat-Zinn, J.  (2003).  Mindfulness-based interventions in context: Past, present, and 
future.  Clinical Psychology: Science and Practice, 10(2), 144-56.   
Kemeny, M.E. (2006). Emotions and the immune system. In R. Ader (Ed.), 
Psychoneuroimmunology (pp. 619-629), New York: Academic Press. 
Keng, S.L., Smoski, M., Robins, C. (2011). Effects of mindfulness of psychological 
health: A review of empirical studies. Clinical Psychology Review, 31, 1041-
1056. 
Kenny, M. A. & Williams, J. M. G. (2006). Treatment-resistant depressed patients show 
a good response to mindfulness-based cognitive therapy. Behaviour Research and 
Therapy, 45, 617-625.  
Kingston, T., Dooley, B., Bates, A., Lawlor, E., & Malone, K. (2007). Mindfulness-based 
cognitive therapy for residual depressive symptoms. Psychology and 
Psychotherapy: Theory, Research, and Practice, 80, 193-203. 
Lawrence, J. M., Standiford, D. A., Loots, B., Klingensmith, G. J., Williams, D. E., 
Ruggiero, A., et al., (2006). Prevalence and correlates of depressed mood among 
youth with diabetes: The SEARCH for diabetes in youth study. Pediatrics, 117, 
1348-1358. 
Ma, S., & Teasdale, J. (2004). Mindfulness-based cognitive therapy for depression; 
Replication and exploration of differential relapse prevention effects. Journal of 
Consulting and Clinical Psychology, 72(1), 31-40. 
  39  
McKenzie, M.J., Carlson, L.E., & Speca, M. (2005). Mindfulness-based stress reduction 
(MBSR) in oncology: Rationale and review.  Evidence-Based Integrative 
Medicine, 2(3), 139-145. 
National Institute of Mental Health (2009). Depression: A treatable illness. Retrieved 
July 1, 2009, from http://www.mentalhealth.gov/health/publications/depression-a-
treatable-illness-fact-sheet/index.shtml. 
O’Connor, M., Bower, J.E., Cho, H.J., Creswell, J.D., Dimitrov, S., Hamby, M.E., Hoyt, 
M.A., Martin, J.L., Robles, T.F., Sloan, E.K., Thomas, K.S., & Irwin, M.R. (in 
press). To assess, to control, to exclude: Effects of biobehavioral factors on 
circulating inflammatory markers.  Brain, Behavior, and Immunity.  
Pace, T.W.W., Lobsang, T.N., Adame, D.D., Cole, S.P, Sivilli, T.I., Brown, T.D., Issa, 
M.J., and Raison, C.L. (2009). Effect of compassion meditation on 
neuroendocrine, innate immune and behavioral responses to psychosocial stress. 
Psychoneuroendocrinology, 34, 87-98. 
Pezelj-Ribaric, S., Brekalo-Prso, Abram, M., Glazar, I., Brumini, G., & Simunovic-
Soskic, M. (2004). Salivary levels of tumor necrosis factor-alpha in oral lichen 
planus. Mediators of Inflammation, 13(2), 131-133. 
Piet, J. & Hougaard, E. (2011). The effect of mindfulness-based cognitive therapy for 
prevention of relapse in recurrent major depressive disorder: A systematic review 
and meta-analysis. Clinical Psychology Review, 31, 1032-1040. 
Pollak, Y., and Yirmiya, R. (2002). Cytokine-induced changes in mood and behavior: 
Implications for “depression due to a general medical condition“, immunotherapy 
and antidepressive treatment. International Journal of 
Neuropsychopharmacology, 5, 389-399. 
Radloff, L.S. The CES-D: A Self-report depression scale for research in the general 
population. Applied Psychological Measurement, 1, 385-401. 
Ree, M. J. & Craigee, M. A. (2007). Outcomes following mindfulness-based cognitive 
therapy in a heterogeneous sample of adult outpatients. Behaviour Change, 24, 
70-86. 
Rudisch, B. and Nemeroff, C.B. (2003). Epidemiology of comorbid coronary artery 
disease and depression. Biological Psychiatry, 54, 227-240. 
  40  
Ryff, C. (1989). Happiness is everything, or is it? Explorations on the meaning of 
psychological well-being. Journal of Personality and Social Psychology, 
57,1069-1081. 
Sauer, S.E., Walsh, E., Lykins, E., & Eisenlohr-Moul, T. (under review). Dismantling 
mindfulness-based stress reduction: Differential effects of sitting meditation, body 
scan, and yoga 
Schlotz, W., Hellhammer, J., Schulz, P., & Stone, A. A. (2004). Perceived work overload 
and chronic worrying predict weekend-weekday differences in the cortisol 
awakening response. Psychosomatic Medicine, 66(2), 207-214. 
Segal, Z. V., Williams, J. M. G., & Teasdale, J. D. (2002). Mindfulness-based cognitive 
therapy for depression: A new approach to preventing relapse. New York: 
Guilford Press. 
Segerstrom, S.C. (2009). Biobehavioral controls: Threats to psychoneuroimmunological 
research? Brain, Behavior, and Immunity. 
Sjogren, E., Leanderson, P., Kristenson, M., & Ernerudh., J. (2006). Interleukin-6 levels 
in relation to psychosocial factors: Studies on serum, saliva, and in vitro 
production by blood mononuclear cells. Brain, Behavior, and Immunity, 20, 270-
278. 
Singer, J. D., & Willett, J.B. (2003). Applied longitudinal data analysis: Modeling change 
and event occurrence. New York: Oxford University Press.   
Stanton, A. L., Danoff-Burg, S., Cameron, C. L., & Ellis, A. P. (1994). Coping through 
emotional approach: Problems of conceptualisation and confounding. Journal of 
Personality and Social Psychology, 66, 350-362. 
Tang, Y.Y., Ma, Y., Wang, J., Fan, Y., Feng, S., Lu, Q., Yu, Q., Sui, D., Rothbart, M.K., 
Fan, M. & Posner, M.I. (2007). Short-term meditation training improves attention 
and self-regulation. Proceedings of the National Academy of Sciences, 104, 
17152-17156. 
Teasdale, J.D., Segal, Z.V., Williams, J.M., Ridgeway, V.A., Soulsby, J.M., & Lau, M.A.  
(2000).  Prevention of relapse/recurrence in major depression by mindfulness-
based cognitive therapy.  Journal of Consulting and Clinical Psychology, 4, 615-
623. 
  41  
Thomsen, D.K., Mehlsen, M.Y., Christensen, S., Zachariae, R. (2003). Rumination-
relationship with negative mood and sleep quality. Personality and Individual 
Differences, 34, 1293-1301. 
Thomsen, D.K., Mehlsen, M.Y., Olesen, F., Hokland, M., Viidik, A., Avlund, K., & 
Zachariae, R. (2004a). Is there an association between rumination and self-
reported physical health? A one-year follow-up in a young and an elderly sample. 
Journal of Behavioral Medicine, 27, 215– 31. 
Thomsen, D.K., Mehlsen, M.Y., Olesen, F., Hokland, M., Viidik, A., Avlund, K., Munk, 
K., & Zachariae, R. (2004b). Negative thoughts and health: associations among 
rumination, immunity, and health care utilization in a young and elderly sample. 
Psychosomatic Medicine, 66, 363– 71. 
Tishler, M., I. Yaron, I. Shirazi, Y. Yossipov, M. Yaron. (1999). Increased salivary 
interleukin-6 levels in patients with primary Sjögren’s syndrome. Rheumatology 
International, 18, 125-127. 
Uebelacker, L., Epstein-Lubow, G., Gaudiano, B., Tremont, B., Battle, C., Miller, I. 
(2010). Hatha yoga for depression: Critical review of the evidence for efficacy, 
plausible mechanisms of action, and directions for future research. Journal of 
Psychiatric Practice, 16, 22-33. 
Wichers, M.C., Kenis, G., Leue, C., Koek, G., Robaeys, G., & Maes, M. (2006). Baseline 
immune activation as a risk factor for the onset of depression during interferon-
alpha treatment. Biological Psychiatry, 60, 77-79. 
Witek-Janusek, L., Albuquerque, K., Rambo-Chroniak, K., Chroniak, C., Durazo-Arvizu, 
R., and Mathews, H.L. (2008). Effects of mindfulness based stress reduction on 
immune function, quality of life and coping in women newly diagnosed with early 
stage breast cancer. Brain, Behavior, and Immunity, 22, 969-981. 
Zorilla, E.P., Luborsky, L., McKay, J.R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, 
R., Seligman, D.A., and Schmidt, K. (2001). The relationship of depression and 
stressors to immunological assays: A meta-analytic review. Brain, Behavior, and 
Immunity, 15, 199-226. 
 
 
  42  
Vita 
 
Erin Celine Walsh 
 
Date of Birth:  May 27, 1981 
Place of Birth:  Washington, D.C. 
 
Education:   
University of Kentucky, Lexington, Kentucky 
M.S., Clinical Psychology, 2008 
 
University of Arizona, Tucson, Arizona 
B.A. magna cum laude, Psychology and Anthropology, 2003  
 
Professional Positions: 
University of Wisconsin-Madison, Wisconsin Psychiatric Institute and Clinic 
Clinical Psychology Intern, July 2011 – Present 
 
University of Kentucky, Lexington, KY 
Researcher, Center for Drug Abuse Research Translation, May 2009 – June 2011 
 
University of Kentucky, Jesse G. Harris Psychological Services Center 
Mindfulness-Based Stress-Reduction (MBSR) Group Leader, Spring 2008 – Spring 2010 
 
University of Kentucky, Family and Community Medicine  
Student Therapist, September 2008 – May 2009 
 
University of Kentucky, Jesse G. Harris Psychological Services Center 
Student Therapist, January 2007 – March 2010 
 
American Psychological Association of Graduate Students, Lexington, KY 
Campus Representative, April 2007 – April 2008 
 
University of Kentucky, Lexington, KY 
Researcher, Behavioral Sciences Trainee, May 2006 – June 2009 
 
University of Kentucky, Lexington, KY 
Teaching Assistant, Research Methods, January 2006 – Summer 2007 
 
University of Kentucky, Lexington, KY 
Teaching Assistant, Developmental Psychology, January 2006 – May 2006 
 
University of Arizona, Tucson, AZ 
Research Lab Manager, Language Development Lab, 2004 – 2005 
 
University of Arizona, Tucson, AZ 
  43  
Undergraduate Research Assistant, Sleep Research Lab, 2002 – 2003 
 
Professional Honors: 
Varela Research Awardee, Mind and Life Institute, 2010-2011 
Research Fellow, Mind and Life Summer Institute, 2008  
First Annual Cognitive Science Day Best Poster Winner, University of Kentucky, 2008 
Dean’s List, University of Arizona, 2000 – 2003 
 
Professional Publications: 
Baer, R.A. & Walsh, E. (in press). Treating acute depression with mindfulness-based 
cognitive therapy. In P. Fisher & A. Wells (Eds.), Treating depression: Principles 
and practice of CBT, MCT and Third Wave Therapies. Chichester, UK: John 
Wiley & Sons. 
 
Walsh, E. (2011). [Review of the book : The art and science of mindfulness: Integrating 
mindfulness into psychology and the helping professions], Journal of 
Psychosomatic Research   
 
Small, B.J., Sharp-Rawson, K., Walsh, E., Jim, H.S.L., Hughes, T.F., Iser, L., 
Andrykowski, M.A., & Jacobsen, P.B. (2011). Catechol-O-Methyltransferase 
(COMT) genotype modulates cancer treatment-related cognitive deficits in breast 
cancer survivors, Cancer 
Derefinko, K., Metze, A., DeWall, C.N., Walsh, E., Lynam, D. (2011). Do different 
facets of impulsivity predict different types of aggression? 
 
Elder, W.G & Walsh, E. (2010). Personality disorders: In J. South-Paul, S.C. Matheny & 
E.L. Lewis (Eds.), Current Diagnosis and Treatment in Family Medicine 
 
Andrykowski, M.A. , Burris, J., Walsh, E., Roberts, B., & Jacobsen, P. (2010). Attitudes 
towards information about genetic risk for cognitive impairment after cancer 
chemotherapy: Breast cancer survivors vs. healthy controls, Journal of Clinical 
Oncology 
Baer, R.A., Walsh, E., & Lykins, E.  (2008).  Assessment of mindfulness. In F. Didonna 
(Ed.), Clinical Handbook of Mindfulness. New York, NY: Springer. 
 
Baer, R.A., Smith, G. T., Lykins, E., Button, D., Krietemeyer, J., Sauer, S., Walsh, E., 
Duggan, D. & Williams, M. (2008).  Construct validity of the Five Facet Mindfulness 
Questionnaire in meditating and non-meditating samples.  Assessment, 15(3), 329-
342.  
 
Sauer, S.E., Walsh, E., Lykins, E., & Eisenlohr-Moul, T. (under review). Dismantling 
mindfulness-based stress reduction:  Differential effects of sitting meditation, 
body scan, and yoga 
 
  44  
Eisenlohr-Moul, T.A., Walsh, E., Baer, R.A. & Milich, R. (under review). Trait 
mindfulness and substance use: does the quality of observation matter? 
 
Walsh, E., Eisenlohr-Moul, T., & Milich, R. (2011, March). The role of mindfulness in 
drinking behavior among college students. Poster to be presented at the annual 
conference for Integrating Mindfulness-Based Interventions into Medicine, Health 
Care, and Society for Clinicians, Researchers, and Educators, Norwood, MA. 
 
Eisenlohr-Moul, T., Walsh, E., & Milich, R. (2011, March). Relating the Five Facet 
Mindfulness Questionnaire (FFMQ) to substance use and abuse in college 
students. Poster to be presented at the annual conference for Integrating 
Mindfulness-Based Interventions into Medicine, Health Care, and Society for 
Clinicians, Researchers, and Educators, Norwood, MA. 
 
Walsh, E., Derefinko, K., Milich, R., & Lynam, D.  (2010, June). Psychophysiological 
response to stress: A potential mediator of negative urgency and alcohol use.  
Poster present at the Research Society on Alcoholism, San Antonio, TX. 
 
Andrykowski, M., Walsh, E., Small, B, Jacobsen, P. (2009). Attitudes towards 
information about genetic risk for cognitive impairment after chemotherapy: 
Breast cancer survivors vs. healthy controls. Paper present at the Annual Meeting 
of the Society of Behavioral Medicine, April, 2009, Montreal, Quebec, Canada. 
 
Sauer, S.E., Baer, R.A., Lykins, E., & Walsh, E. (2008). Dismantling mindfulness-based 
stress reduction: Relationships between sitting meditation, body scan, and yoga 
and psychological health. Poster present at the annual meeting of the Association 
for Behavioral and Cognitive Therapy, Orlando, FL. 
    
Walsh, E., Sauer, S., & Baer, R.A. (2008, April). Acceptance and regulation of unwanted 
thoughts: Relationships with mental Health and well-being. Poster present at the 
annual conference for Integrating Mindfulness-Based Interventions into Medicine, 
Health Care, and Society for Clinicians, Researchers, and Educators, Worcester, 
MA. 
 
Walsh, E. & Baer, R.A. (2008, February). Mindfulness and experiential avoidance in a 
laboratory stressor. Poster present at the University of Kentucky’s Cognitive 
Science Day, Lexington, KY. 
 
Button, D. F., Krietemeyer, J., Lykins, E., Sauer, S., Walsh, E. & Baer, R.A. (2006, 
November). Mindfulness as a mediator: Meditation increases mindfulness and 
reduces fear of affect and experiential avoidance. Poster present at the annual 
meeting of the Association for Behavioral and Cognitive Therapy, Chicago, IL.  
 
Lykins, E., Button, D. F., Krietemeyer, J., Sauer, S., Walsh, E. & Baer, R.A. (2006, 
November). Meditation, mindfulness, and self-compassion in a sample of 
experienced meditators. Poster present at the annual meeting of the Association 
  45  
for Behavioral and Cognitive Therapy, Chicago, IL. 
